Skip Nav Destination
Progressive silent cerebral infarction is associated with stroke and persistent cognitive impairment in survivors of iTTP
Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R follicular lymphoma: phase 1/2 BRUIN study
Association of PET4 response with outcomes of BV-CHP vs CHOP in the ECHELON-2 trial in CD30+ peripheral T-cell lymphoma
International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML
Issue Archive
December 9 2025
In Progress
CLINICAL TRIALS AND OBSERVATIONS
Progressive silent cerebral infarction is associated with stroke and persistent cognitive impairment in survivors of iTTP
Clinical Trials & Observations
Jia Yu,Jenna Brown,Jay Meade,Gloria F. Gerber,Michael B. Streiff,Peggy Kraus,Samuel Merrill,Allyson M. Pishko,Jennifer Yui,Rakhi P. Naik,Robert A. Brodsky,Doris D. Lin,Shruti Chaturvedi
Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R follicular lymphoma: phase 1/2 BRUIN study
Clinical Trials & Observations
Nirav N. Shah,Pier Luigi Zinzani,Michael Wang,Sunita D. Nasta,Ewa Lech-Maranda,Yoshiaki Ogawa,Bita Fakhri,Bryone Kuss,Kaname Miyashita,Krish Patel,Catherine C. Coombs,Shuo Ma,Manish R. Patel,Minal A. Barve,Benoit Tessoulin,Anastasios Stathis,Daisuke Ennishi,Daigo Hashimoto,Kensuke Kojima,Andrew D. Zelenetz,Jonathon B. Cohen,Julie M. Vose,Kami J. Maddocks,Talha Munir,Fangfang Sun,Yuanyuan Bian,Minna Balbas,Donald E. Tsai,Paolo Abada,Chan Y. Cheah
Association of PET4 response with outcomes of BV-CHP vs CHOP in the ECHELON-2 trial in CD30+ peripheral T-cell lymphoma
Clinical Trials & Observations
Swaminathan Iyer,Neha Mehta-Shah,Ranjana Advani,Nancy L. Bartlett,Jacob H. Christensen,Franck Morschhauser,Eva Domingo-Domenech,Giuseppe Rossi,Won Seog Kim,Onder Alpdogan,Tatyana A. Feldman,Vincent Camus,Giuseppe Gritti,Pier Luigi Zinzani,David Belada,Jiri Mayer,Ilseung Choi,June-Won Cheong,Evelyn Rustia,Keenan Fenton,Michelle Fanale,Kerry J. Savage,Steven M. Horwitz
International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML
Clinical Trials & Observations
Swati Naik,Richard Aplenc,Susanne H.C. Baumeister,Marco Becilli,Anand S. Bhagwat,Challice L. Bonifant,Lihua E. Budde,Christopher D. Chien,Kevin J. Curran,Anthony F. Daniyan,Alexandra Dreyzin,Rebecca A. Gardner,Sara Ghorashian,Stephen Gottschalk,LaQuisa C. Hill,M. Eric Kohler,Adam Lamble,Franco Locatelli,Maksim Mamonkin,Bilal Omer,Jae H. Park,Concetta Quintarelli,Benedetta Rambaldi,Rebecca M. Richards,David A. Sallman,Tim Sauer,Nirali N. Shah,Marion Subklewe,Corinne Summers,Sarah K. Tasian,Naomi Taylor,Sarah Tettamanti,Michael R. Verneris,M. Paulina Velasquez,Saar I. Gill
ADVANCES VIEWPOINT
MYELOID NEOPLASIA
Cardiovascular degeneration in Erdheim-Chester disease: prevalence, burden, and outcomes
Reema K. Tawfiq,Grant M. Spears,Jason R. Young,Madeline K. Mahowald,W. Oliver Tobin,Ubenthira Patgunarajah,Gordon J. Ruan,Dongni Yi,Saurabh Zanwar,Karen Rech,Matthew J. Koster,Aldo A. Acosta-Medina,Lucinda Gruber,Aishwarya Ravindran,Mithun Vinod Shah,N. Nora Bennani,Muhamad Alhaj Moustafa,Talal Hilal,Julio C. Sartori Valinotti,Robert Vassallo,Jay H. Ryu,Caroline Davidge-Pitts,Surendra Dasari,Thomas E. Witzig,Ronald S. Go,Gaurav Goyal,Jithma P. Abeykoon,on behalf of the Histio-Care Network
Lymphoid Neoplasia
Risk of synchronous and second primary malignancies in transplant-ineligible patients with multiple myeloma treated with lenalidomide
Thomas Systchenko,Laly Nsiala,Arthur Bobin,Hélène Gardeney,Carine Motard,Gaelle Olivier,Florence Borde,Anne Corby,Christophe Roul,Emmanuel Fleck,Guillaume Denis,Céline Dieval,Philippe Mottaz,Annick Boscagli,Gautier Defossez,Xavier Leleu
Identification of 4 autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia
Antonio José Cabrera-Serrano,José Manuel Sánchez-Maldonado,Juan José Rodríguez-Sevilla,Fernando Jesús Reyes-Zurita,Rosa Collado,Anna Puiggros,Elena Cornejo-Calvo,Paloma García-Martín,Rob Ter Horst,Yolanda Benavente,Andrés Jerez,Stefano Landi,Blanca Espinet,Rossana Maffei,Miguel Ángel López-Nevot,Silvia Ramos-Campoy,Carmen González-Olmedo,Tzu-Hua Chen-Liang,Víctor Moreno,Fatin Jannus,Rafael Marcos-Gragera,María Carretero-Fernández,Belém Sampaio-Marques,Irene Gámez,María García-Álvarez,Nicola J. Camp,Trinidad Dierssen-Sotos,Joanna Kamaso,Eva María Pérez,Aaron D. Norman,Mario Luppi,Yang Li,Miguel Alcoceba,Daniele Campa,Silvia de San José,Roberto Marasca,Paula Ludovico,Alyssa Clay-Gilmour,Federico Canzian,Marian Ibañez,Mihai G. Netea,James McKay,Delphine Casabonne,Sonja I. Berndt,Susan L. Slager,Juan Sainz
Plasma Cell Disorders
Safety and efficacy of BCMA-directed chimeric antigen receptor T-cell therapy for the treatment of plasma cell leukemia
Gliceida M. Galarza Fortuna,Lauren Peres,Elena Nazarenko,Andre De Menezes Silva Corraes,Vanna N. Hovanky,Leyla Shune,Joseph McGuirk,Gabriel De Avilla,Jack Khouri,Danai Dima,Mahmoud Gaballa,Binod Dhakal,Peter Forsberg,Amandeep Godara,Aimaz Afrough,Larry Anderson,Megan M. Herr,James A. Davis,Hashim Mann,Sneha Purvey,William Clark,Myo Htut,Amer Beitinjaneh,Denise L. Pereira,Mehmet H. Kocoglu,Christopher James Ferreri,Shebli Atrash,Peter M. Voorhees,Adriana Rossi,Richard Shambavi,Hamza Hashmi,Krina Patel,Surbhi Sidana,Yi Lin,Doris K. Hansen,Douglas W. Sborov
THROMBOSIS AND HEMOSTASIS
Inside Blood Advances
RESEARCH LETTER
Advertisement intended for health care professionals
Advertisement intended for health care professionals










